22-Jul-2025 7:15 AM CST - Business Wire Aditxt to Present at Wall Street Reporters Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ET Aditxt, Inc. (Nasdaq: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, today announced a live discussion focused on its wholly owned subsidiary Adimune, Inc. (Adimune), which is advancing therapeutics designed to address autoimmune diseases. The livestream, hosted by Jack Marks of Wall Street Reporter, will take place on July 22, 2025, at 1:00 p.m. ET and will feature Amro Albanna, Co-founder a
26-Jun-2025 7:15 AM CST - Business Wire Aditxt to Present at Wall Street Reporters NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, is pleased to announce that Co-founder and CEO Amro Albanna will be presenting at Wall Street Reporters NEXT SUPER STOCK livestream event on June 26, 2025 at 1:00 p.m. ET. Mr. Albanna will discuss Aditxts innovation acceleration business model, overview and status of Aditxts two programs with focus on autoimmunity and early c
5-Jun-2025 7:15 AM CST - Business Wire Saundra Pelletier, Evofem Biosciences CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6 Aditxt, Inc. (Nasdaq: ADTX) (Aditxt), a social innovation platform accelerating promising health innovations, today announced that its CEO Amro Albanna will be joined for tomorrows Aditxt Weekly Update by Dr. Friedrich Kapp, Chris Mitton, and Evofem Biosciences CEO Saundra Pelletier to discuss progress in immune therapy, early disease detection and womens health, respectively. Event Details: Title: Aditxt Weekly Update Date: Friday, June 6, 2025 Time
11-Apr-2025 7:15 AM CST - Business Wire Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, announced that todays Aditxt Weekly Update will provide key updates on recent events, including: Aditxts recent notice from Nasdaq that it had regained compliance with Nasdaqs minimum bid price requirement and is therefore in compliance with the Nasdaq Capital Markets listing requirements Updates on the Companys operating s
28-Mar-2025 7:15 AM CST - Business Wire Upcoming Aditxt Weekly Update to Highlight Pearsantas Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer Detection Aditxt, Inc. (NASDAQ: ADTX), (Aditxt or the Company), a social innovation platform accelerating promising health innovations, announced that todays Aditxt Weekly Update will focus on the recent acquisition of the CaSe Platform by its subsidiary, Pearsanta, Inc. (Pearsanta). The proprietary technology is based on adductomics and is designed to assess early DNA changes that may lead to mutations associated with cancer and other illnesses. The discuss
13-Feb-2025 7:15 AM CST - Business Wire Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time Aditxt, Inc. (Aditxt or the Company) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced that it will host a virtual Fireside Chat on Friday, February 21, 2025, at 11:30 AM Eastern Time. The event will feature Amro Albanna, CEO of Aditxt, who will provide updates on key corporate developments, including the status of current subsidiaries, potential transactions, and notable advancements
30-Oct-2024 4:00 PM CST - Business Wire Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a social innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A session with CEO Amro Albanna this Friday, November 1, 2024, at 11:30 AM ET. This update aims to connect with our stakeholders, including investors and the public, offering insights into the Companys latest developments and will address pre-submitted questions. T
22-Jul-2025 7:15 AM CST - Business Wire Aditxt to Present at Wall Street Reporters Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ET Aditxt, Inc. (Nasdaq: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, today announced a live discussion focused on its wholly owned subsidiary Adimune, Inc. (Adimune), which is advancing therapeutics designed to address autoimmune diseases. The livestream, hosted by Jack Marks of Wall Street Reporter, will take place on July 22, 2025, at 1:00 p.m. ET and will feature Amro Albanna, Co-founder a
26-Jun-2025 7:15 AM CST - Business Wire Aditxt to Present at Wall Street Reporters NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, is pleased to announce that Co-founder and CEO Amro Albanna will be presenting at Wall Street Reporters NEXT SUPER STOCK livestream event on June 26, 2025 at 1:00 p.m. ET. Mr. Albanna will discuss Aditxts innovation acceleration business model, overview and status of Aditxts two programs with focus on autoimmunity and early c
5-Jun-2025 7:15 AM CST - Business Wire Saundra Pelletier, Evofem Biosciences CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6 Aditxt, Inc. (Nasdaq: ADTX) (Aditxt), a social innovation platform accelerating promising health innovations, today announced that its CEO Amro Albanna will be joined for tomorrows Aditxt Weekly Update by Dr. Friedrich Kapp, Chris Mitton, and Evofem Biosciences CEO Saundra Pelletier to discuss progress in immune therapy, early disease detection and womens health, respectively. Event Details: Title: Aditxt Weekly Update Date: Friday, June 6, 2025 Time
11-Apr-2025 7:15 AM CST - Business Wire Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, announced that todays Aditxt Weekly Update will provide key updates on recent events, including: Aditxts recent notice from Nasdaq that it had regained compliance with Nasdaqs minimum bid price requirement and is therefore in compliance with the Nasdaq Capital Markets listing requirements Updates on the Companys operating s
28-Mar-2025 7:15 AM CST - Business Wire Upcoming Aditxt Weekly Update to Highlight Pearsantas Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer Detection Aditxt, Inc. (NASDAQ: ADTX), (Aditxt or the Company), a social innovation platform accelerating promising health innovations, announced that todays Aditxt Weekly Update will focus on the recent acquisition of the CaSe Platform by its subsidiary, Pearsanta, Inc. (Pearsanta). The proprietary technology is based on adductomics and is designed to assess early DNA changes that may lead to mutations associated with cancer and other illnesses. The discuss
13-Feb-2025 7:15 AM CST - Business Wire Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time Aditxt, Inc. (Aditxt or the Company) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced that it will host a virtual Fireside Chat on Friday, February 21, 2025, at 11:30 AM Eastern Time. The event will feature Amro Albanna, CEO of Aditxt, who will provide updates on key corporate developments, including the status of current subsidiaries, potential transactions, and notable advancements
30-Oct-2024 4:00 PM CST - Business Wire Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a social innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A session with CEO Amro Albanna this Friday, November 1, 2024, at 11:30 AM ET. This update aims to connect with our stakeholders, including investors and the public, offering insights into the Companys latest developments and will address pre-submitted questions. T
